Corti, the leading AI and research company in healthcare, today announced it is collaborating with Wolters Kluwer Health to integrate its market-leading clinical decision support solution, UpToDate®, ...

The global Medical Device Contract Manufacturing market size was $73.61 billion in 2023 and is projected to reach $81.19 ...

CROPrime, a specialist in clinical trial site selection and feasibility, is offering its expertise to biotech and pharmaceutical companies seeking to collaborate with leading UK hospitals for their ...

Telepharmacy — the delivery of pharmaceutical services over telecommunication technology — is booming. As more pharmaceutical ...

Qureight Ltd, a Core Imaging Laboratory developing deep-learning image analytics, and Vicore Pharma, a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 ...

A new robotic procedure designed to provide relief for men with an enlarged prostate is now available in the Midlands, offering another option for treatment for men in the region. Benign prostatic ...

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to ...

Oxford Drug Design has been awarded £1m in funding to progress its uUTI (uncomplicated urinary tract infection) antibacterial programme, as announced by PACE (Pathways to Antimicrobial Clinical ...

According to the preliminary figures for 2024, Krones continued its stable and profitable growth in the past financial year, despite difficult macroeconomic conditions. As a leading supplier of ...

ACG Capsules, a global leader in capsule manufacturing, introduces the first fully vegan printed capsules, marking a significant advancement in the pharmaceutical and nutraceutical industries. Made ...

The International Air Cargo Association (TIACA) announced the official nomination period for the of Two new industry leadership awards has opened. The two new awards are designed to recognize ...

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today presented positive, final data from the ...